The method of using a small amount of stimulant drugs has been known by famous tech workers in Silicon Valley, who claim this method stimulates their creativity and improves their performance at work.
But now others are increasingly turning to self-medication strategies, according to Adam Winstock, founder Global Drug Survey (GDS).
“In the past, people used microdosing to enhance productivity and creativity,” he said Guardians.
“Now, I think people are turning to microdosing to promote health and solve mental health problems.”
This year’s GDS poll, conducted between December 2020 and March 2021, found that 22% of people who used psychedelic drugs – such as LSD and magic mushrooms – had been infected. micropoint.
In this group, half took only a small dose while the other half also took the full dose.
Although most of those small doses reported no side effects, 10% had mental undesirable effects and 8% had physical undesirable effects.
Of the roughly 20% of microdoser users taking medication to treat their mental health, a quarter stopped taking their prescribed psychiatric medication and another quarter reduced their dosage.
The authors of the GDS report said: “Clinical trials have not yet been able to determine whether micro-dose hallucinogens for mental health treatment are really effective, but we expect trials like so in the future – both in normal doses and in small doses.”
Researchers at Imperial College London have previously suggested that reports of health enhancements from the use of micro-psychedelic drugs may be caused by the placebo effect.
Dr David Erritzoe, who runs the university’s Center for Psychedelic Research, said more trials are needed to determine if the approach has any health benefits.
The 2021 GDS survey, with 3,000 respondents, shows that psychedelic use is on the rise and is significantly higher than the levels seen in 2015.
https://www.independent.co.uk/news/health/psychedelics-consumption-pandemic-global-drug-survey-b1968383.html People ‘microdosing’ hallucinogens to improve health during pandemic, drug survey finds